WELLS FARGO & COMPANY/MN - NOVABAY PHARMACEUTICALS INC ownership

NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P201. A total of 22 filers reported holding NOVABAY PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of NOVABAY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$0284
+3.3%
0.00%
Q2 2022$0275
+15.1%
0.00%
Q1 2022$0239
+11.2%
0.00%
Q4 2021$0215
+7.5%
0.00%
Q3 2021$0200
+17.6%
0.00%
Q2 2021$0170
-0.6%
0.00%
Q1 2021$01710.0%0.00%
Q4 2020$0
-100.0%
171
-97.7%
0.00%
Q3 2020$5,000
-37.5%
7,514
+1.2%
0.00%
Q2 2020$8,000
+100.0%
7,4280.0%0.00%
Q1 2020$4,000
-20.0%
7,428
+1.0%
0.00%
Q4 2019$5,0007,3530.00%
Other shareholders
NOVABAY PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Virtu Financial LLC 52,301$36,0000.00%
TOWNSQUARE CAPITAL LLC 53,672$37,0000.00%
REILLY FINANCIAL ADVISORS, LLC 17,500$12,0000.00%
NVWM, LLC 2,997$2,0000.00%
Advisory Services Network, LLC 20,500$14,0000.00%
VANGUARD GROUP INC 160,224$112,0000.00%
UBS Group AG 10,353$7,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 25,000$17,0000.00%
Sugarloaf Wealth Management, LLC 2,000$1,0000.00%
OSAIC HOLDINGS, INC. 3,260$3,0000.00%
View complete list of NOVABAY PHARMACEUTICALS INC shareholders